Clinical trial
Long-term Follow up Helicobacter Pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple Therapy
NCT01792700 is registered in ClinicalTrials.gov with Seoul National University Bundang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-term Follow up Helicobacter Pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple Therapy
- Lead sponsor
- Seoul National University Bundang Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2003
- Completion date
- December 31, 2010
- Enrollment
- 648 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.